R Basu, P Shah, A Basu, B Norby, B Dicke, V … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Glucose was clamped before and after therapy at ∼5 mmol/l, insulin raised to
∼180 pmol/l, C-peptide suppressed with somatostatin, glucagon replaced at ∼75 pg/ml, and
glycerol maintained at ∼200 mmol/l to ensure comparable and equal portal ... Cited by 10 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org A Gastaldelli, Y Miyazaki, A Mahankali, R Berria, M … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Fasting plasma glucose (FPG) (10.0 ± 0.8 to 7.7 ± 0.7 mmol/l) and HbA 1c (9.0 ±
0.4 to 7.3 ± 0.6%) decreased in the PIO and increased in Plc group (P < 0.05 PIO vs. Plc). Insulin
sensitivity increased ∼40% during high insulin clamp after pioglitazone (P < 0.01) and ... Cited by 24 - Related articles - BL Direct - All 5 versions
A Gastaldelli, A Casolaro, M Pettiti, M Nannipieri, … - Clinical Pharmacology & …, 2007 - nature.com We explored the mechanisms by which a 4-month, placebo-controlled pioglitazone treatment
(45 mg/day) improves glycemic control in type II diabetic patients (T2D, n=27) using physiological
testing (6-h mixed meal) and a triple tracer technique ([6,6- 2 H 2 ]glucose infusion, 2 H 2 ... Cited by 8 - Related articles - All 4 versions
- ►endojournals.org MJ Serlie, G Allick, JE Groener, MT Ackermans, … - Journal of Clinical …, 2007 - Endocrine Soc Design: We studied glucose metabolism in the basal state and during a hyperinsulinemic euglycemic
clamp by using stable isotopes. Studies were performed at baseline and after 4 months of treatment
with pioglitazone. Patients were then studied on a third occasion during infusion of a lipid ... Cited by 12 - Related articles - BL Direct - All 4 versions
M Roden, S Mariz, AR Brazzale, G Pacini - Journal of Internal Medicine, 2009 - pt.wkhealth.com Roden M, Mariz S, Brazzale AR, Pacini G (Heinrich Heine University, Düsseldorf, Germany;
Karl-Landsteiner Institute for Endocrinology and Metabolism, Vienna, Austria; Takeda Global
Research & Development Centre (Europe) Ltd, London, UK; and Institute of Biomedical ... Related articles - All 5 versions
R Basu, V Chandramouli, B Dicke, BR Landau, RA … - Diabetes, 2008 - Am Diabetes Assoc RESULTS—Plasma C2 glucose and plasma 2 H 2 O enrichment were equal in both groups before
the clamp, resulting in equivalent estimates of gluconeogenesis and glycogenolysis. In
contrast, plasma C2 glucose and plasma C5 glucose enrichments fell throughout the ... Related articles - All 5 versions
TP GmbH - gripsdb.dimdi.de Im Sommer 2005 wurde im Auftrag von Takeda Pharma GmbH ein HTA-Bericht mit dem Titel
„Bewertung des Mehrnutzens der Therapie mit Glitazonen im Vergleich zur Therapie mit Metformin
oder Sulfonylharnstoffen bei der Behandlung des Typ 2 Diabetes mellitus“ erstellt. Dieser ... Related articles
J Cuthbertson, S Patterson, FPM O'Harte, PM … - Diabetic …, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Related articles - All 3 versions
